A business case assessment for a novel mAb product
A business case assessment for a novel mAb product identified for the treatment of severe asthma. Clinical Development and marketability.
top of page
Darren Wogman MSc
123-456-7890
Search
What are the differences between embryonic stem cells and tissue stems cells?
What are the differences between embryonic stem cells and tissue stems cells? Discuss the efficacy and safety. Darren Wogman MSc
Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study
Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study on treating patients with schizophrenia
A target product profile (TPP) for ATL-104. Use in Oral Mucositis (OM). Darren Wogman MSc
A target product profile (TPP) for ATL-104. Use in Oral Mucositis (OM). Darren Wogman MSc
Clinical pharmacology support studies routinely required for IMP registration.
Clinical pharmacology support studies routinely required for IMP registration. SmPCs, ABA, FDI, ADME, QT, Renal, Hepatic, PopPK, DDI, BE
Research Pieces: Blog2
bottom of page